81,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

This handbook is designed to serve as a compact, up-to-date, and easy-to-use reference on the clinical features and pathology of ocular tumors. It comprises approximately 75 entries that cover the full spectrum of clinically encountered ocular tumors as well as tumor classification and other selected topics. Each entry addressing a given tumor or class of tumors is organized in a standard way, with information on synonyms, definition, etiology, clinical presentation, diagnosis, differential diagnosis, prophylaxis, therapy, prognosis, and epidemiology. Key references are also provided. The book…mehr

Produktbeschreibung
This handbook is designed to serve as a compact, up-to-date, and easy-to-use reference on the clinical features and pathology of ocular tumors. It comprises approximately 75 entries that cover the full spectrum of clinically encountered ocular tumors as well as tumor classification and other selected topics. Each entry addressing a given tumor or class of tumors is organized in a standard way, with information on synonyms, definition, etiology, clinical presentation, diagnosis, differential diagnosis, prophylaxis, therapy, prognosis, and epidemiology. Key references are also provided. The book has the advantage of having been written by members of an ocular oncology group from a leading cancer center, and will be of great practical value for ophthalmologists and ophthalmic pathologists.
Autorenporträt
Hans E. Grossniklaus, MD, MBA, attended Medical School at Ohio State University and subsequently served residencies in ophthalmology and pathology at Case Western Reserve University, Ohio. He is currently the F. Phinizy Calhoun Jr. Professor of Ophthalmology, Director of the L.F. Montgomery Pathology Laboratory, and Director of the Section of Ocular Oncology and Pathology at Emory University School of Medicine, Atlanta, Georgia. Dr. Grossniklaus is board certified in both ophthalmology and anatomic pathology and has expertise in diagnostic ophthalmic pathology and ocular oncology. His research areas of interest include treatment of primary ocular melanoma and retinoblastoma and control of metastatic melanoma from the eye to the liver. He has authored approaching 400 articles in peer-reviewed journals.